R&D Pipeline
| Project | Call | Funding Agency | Role | Activities | Execution Period |
| OLIGOFASTX | MIG-20211028 |  | Partner | Develop a sustainable platform for new therapies based on oligonucleotides (ASOs, siRNAs and aptamers for the treatment of rare diseases. | 2019- 2024 |
| PHITBAC | PLEC2021-007739 |  | Partner | AptusBiotech will be in charge of developing novel aptamers for the detection of specific antibiotics used in clinics | 2019- 2024 |
| AptaBreast | RTC2019-007227-1 |  | Coordinator | Mnk1 aptamer for breast cancer novel therapy. Preclinical Trials in animal models. | 2020 – 2023 |
| PrediApt | RTC2019-007229-1 | | Coordinator | Development of a Predictive System based on Aptamers in response to Treatment with Platinum Derivatives in Lung Cancer | 2020-2023 |
METASTARG | EURONANOMED 2018-045 |  | Partner | Selection of aptamers against a lung cancer marker and their use for targeting in drug delivery and thus interrupting metastatic progression. | 2018-2021 |
| Project | Call | Funding Agency | Role | Activities | ||
| Aptalung | RTC-2017-6597-1 | | Coordinator | Lung Cancer Diagnosis Using Aptamer technology. Applications in analysis of circulating tumor cells (CTCs) and in Apta-histochemistry. | 2018-2021 | |
| AptaVir | RETOS 2016 MINECO (RTC-2016-5302-1) | | Partner | Development and manufacture of portable solutions for direct detection of the Chikungunya virus for rapid diagnosis. | 2016–2019 | |
| MultiDETECT | Programa CDTI-interempresas 2016 EUROSTARS-2 (E9781) |  | Partner | Aptamers against proteins of seven porcine pathogens with the aim of developing a multiple diagnostic kit for the detection of respiratory and digestive infections in swine. | 2015-2018 | |
| ApTOLL | RETOS 2015 MINECO (RTC-2015-3741-1) | | Partner | Preclinical development of a molecule based on aptamer technology specific to TLR-4 and applicable in Acute Stroke and Cardiovascular Diseases (Myocardial Infarction). | 2015-2017 | |
| AptaHCV | RETOS 2014 MINECO (RTC-2014-1986-1) | | Partner | Development and validation of an aptamer-based platform for the detection and genotyping of hepatasis C virus. | 2014-2017 | |
| Subprogramm “Innpacto 2011” | IPT-2011-1057-010000 | | Partner | Development and clinical validation of a Kit to diagnose the evolution of intestinal absorptive mass, using innovative technology based on selective aptamers of the APO A-IV protein | 2011-2014 | |